Fujifilm Rolls Out EN-840T Double Balloon Enteroscopy Scope

Fujifilm Healthcare Americas has begun commercialization of its EN-840T double balloon enteroscopy (DBE) scope, an endoscopic imaging technology that allows access to the whole small intestine for diagnosis and therapeutic intervention.

The scope’s 3.2 mm working channel suits many procedures requiring hemostasis and balloon dilation, according to the company, providing better suction performance than conventional models. It also allows for blood or mucus aspiration while a therapeutic device is inserted, permitting faster hemostasis.

The large working channel makes for easier catheter insertion and removal, before and after dilatation of strictures. The scope also has a dedicated forward water jet channel for irrigation and to quickly clear debris on the mucous membranes for clearer bowel wall visualization.

A CMOS image sensor in the scope creates vivid, HD images. LED multi-light tech and Fujifilm’s Linked Color Imaging (LCI) and Blue Light Imaging (BLI) modes also offer unparalleled visualization, the company claims, and optimal detection during small bowel procedures.

EN-840T DBE provides adaptive bending and advanced force transmission tech for better access and scope maneuverability in challenging anatomy. Adaptative bending of the scope also supports deeper insertion—even through post-surgical adhesions of the intestinal tract.

Additionally, the G7 scope handle grip design is intended to minimize stress and enable intuitive operation.

“The small intestine is one of the most challenging areas in patient anatomy to access in GI endoscopy,” said Tai Fujita, VP, Endoscopy Division, Fujifilm Healthcare Americas Corporation. “By continuing to develop and enhance our double balloon enteroscopy technologies, we are empowering endoscopists and GI physicians to unlock access to difficult to reach pathways within the digestive tract, while simultaneously assisting with diagnosis and treatment for a wide array of diseases of the small intestine, including Crohn’s disease, gastrointestinal bleeding, and removal of small bowel polyps, among others.”

Last month, Fujifilm Healthcare Americas began a partnership with EndoSim, a company specializing in evidence-based endoscopic simulation.